Name: ADMA Income Statement - Adma Biologics Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ADMA - Adma Biologics, Inc.

USD | NASDAQ | Healthcare

ADMA Income Statement - Adma Biologics Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	114.5	139.2	134.2	122.0	114.8	117.5	119.8	107.2	81.9	73.9	67.3	60.1	56.9	50.0	41.1	33.9

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenues
Revenues	509.9	510.2	426.5	258.2	154.1	80.9	42.2	29.3	17.0	22.8	10.7	7.2	5.9	3.1	1.1	0.8
Cost of Revenue	197.4	217.4	206.9	169.3	118.8	79.8	61.3	39.5	42.2	29.2	1.6	4.3	3.7	2.0	0.7	0.2
Gross Profit	312.4	292.8	219.6	88.9	35.3	1.2	(19.1)	(10.2)	(25.2)	(6.4)	9.1	2.9	2.2	1.0	0.4	0.6
Operating Expenses
Research & Development	6.5	4.8	1.8	3.3	3.6	3.6	5.9	2.3	3.9	5.6	7.7	7.0	9.5	9.3	3.5
Operating Income
Operating Income	214.8	191.4	139.0	21.6	(39.4)	(58.4)	(64.9)	(41.4)	(60.3)	(39.3)	(17.3)	(15.5)	(16.0)	(15.0)
Non-Operating
Interest Income	-	1.9	2.1	1.6	0.0	0.0	0.3	0.8	0.2	0.1	0.1	0.0	0.0	0.0	0.0	-
Tax & Net
Income Tax Expense	41.0	35.7	(72.0)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	(0.6)	0.0	(0.6)
Per Share
EPS Basic	0.70	0.62	0.85	(0.13)	(0.33)	(0.51)	(0.88)	-	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	222.7	199.4	146.7	29.2	(33.0)	(53.6)	(61.7)	(39.0)	(57.7)	(37.8)	(16.9)	(15.0)	(15.8)	(14.8)	(7.7)	(4.4)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Income
Operating Income	58.3	62.8	51.0	42.8	34.9	38.3	39.6	39.2	21.8	14.2	8.7	(0.5)	(0.8)	(6.1)	(9.3)	(9.2)	(14.8)	(13.2)	(14.4)	(15.6)	(15.2)	(17.2)	(13.8)	(17.1)	(16.8)	(7.8)	(9.1)	(11.3)	(13.2)	(16.5)	(13.8)	(13.4)	(16.5)	(10.5)	(14.4)	(8.4)	(5.9)	(3.9)	(3.7)	(5.5)

Tax & Net
Income Tax Expense	11.8	12.2	11.1	5.9	6.5	(77.2)	0.8	3.8	0.6	0.0	0.0	0.0	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	45.3	49.4	36.4	34.2	26.9	111.9	35.9	32.1	17.8	(17.6)	2.6	(6.4)	(6.8)	(12.2)	(14.9)	(13.8)	(25.0)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	45.3	49.4	36.4	34.2	26.9	111.9	35.9	32.1	17.8	(17.6)	2.6	(6.4)	(6.8)	(12.2)	(14.9)	(13.8)	(25.0)
Net Income Attributable To Parent	45.3	49.4	36.4	34.2	26.9	111.9	35.9	32.1	17.8	(17.6)	2.6	(6.4)	(6.8)	(12.2)	(14.9)	(13.8)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	45.3	49.4	36.4	34.2	26.9	111.9	35.9	32.1	17.8	(17.6)	2.6	(6.4)	(6.8)	(12.2)	(14.9)

Per Share
EPS Basic	0.19	-	0.15	0.14	0.11	-	0.15	0.14	0.08	-	0.01	(0.03)	(0.03)	-	(0.08)	(0.07)	(0.13)	-	(0.13)	(0.15)	(0.16)	-	(0.19)	(0.23)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	0.19	-	0.15	0.14	0.11	-	0.15	0.13	0.08	-	0.01	(0.03)	(0.03)	-	(0.08)	(0.07)	(0.13)	-
Shares Basic	236.1	-	238.6	241.5	237.8	-	234.6	232.4	228.9	-	225.3	222.7	221.9	-	196.4	196.4	195.9	-
Shares Diluted	240.0	-	244.7	248.6	244.7	-	244.8	242.2	236.4	-	233.8	222.7	221.9	-	196.4	196.4	195.9	-

Supplementary Data
EBITDA	60.1	64.9	53.0	44.8	36.8	40.3	41.5	41.1	23.7	16.1	10.6	1.4	1.1	(4.3)	(7.6)	(7.7)	(13.4)	(11.8)	(13.2)	(14.5)	(14.1)	(16.2)	(12.9)	(16.4)	(16.2)	(7.9)	(8.2)	(10.5)	(12.4)	(16.5)	(12.9)	(12.6)	(15.7)	(10.3)	(13.6)	(8.1)	(5.8)	(3.9)	(3.6)	(5.4)
EBIT	58.3	62.8	51.0	42.8	34.9	38.3	39.6	39.2	21.8	14.2	8.7	(0.5)	(0.8)	(6.1)	(9.3)	(9.2)	(14.8)	(13.2)	(14.4)

Operating Expenses
Research & Development	2.6	1.4	1.5	1.0	0.8	0.4	0.4	0.6	0.5	0.4	0.6	1.4	0.9	1.1	1.0	0.9	0.6	0.7	0.8	1.2	1.0	1.0	1.7	1.7	1.5	0.5	0.5	0.5	0.9	0.9	1.0	1.0	1.0	1.2	1.8	1.4	1.2	0.6	1.7	3.4
Selling General & Administrative	26.7	23.5	21.8	22.2	24.1	23.3	18.6	16.6	15.6	15.5	14.7	14.2	14.5	13.9	12.9	12.0
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	1.8	2.1	2.0	2.0	1.9	2.0	1.9	1.9	1.9	1.9	1.9	1.9	1.9	1.8	1.7	1.5
Amortization of Intangibles	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Other Operating Expenses	1.1	1.1	1.3	1.2	1.3	1.3	1.0	0.9	1.0	0.7	0.5	1.3	1.8	5.1	4.9	3.9	4.0
Total Operating Expenses	22.5	26.1	24.6	24.4	26.2	25.0	20.0	18.3	17.3	16.9	16.0	17.2	17.3	20.2	19.0	16.9

Non-Operating
Interest Income	-	0.5	0.4	0.4	0.6	0.6	0.7	0.4	0.4	0.6	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	2.1	1.6	1.7	1.8	2.0	2.9	3.5	3.8	3.8	6.2	6.4	6.3	6.1	5.7	5.6	4.6	3.4	3.3
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(1.1)	(1.2)	(3.5)	(2.7)	(1.4)	(3.6)	(2.9)	(3.4)	(3.4)	(31.9)	(6.1)	(5.9)	(6.0)	(6.2)	(5.6)	(4.6)	(10.2)
Pre-Tax Income	57.1	61.6	47.5	40.1	33.5	34.7	36.7	35.9	18.4	(17.6)	2.6	(6.4)	(6.8)	-	-	-	-